News & Updates

Novel anti-influenza A virus inhibitor works in patients with uncomplicated flu infection

Treatment with the anti-influenza A virus inhibitor onradivir is safe and leads to symptom improvement and viral load reduction in adults with uncomplicated influenza infection, according to data from a phase II trial.

Needed Now or No More: Review of Evidence and Intricacies of Influenza Vaccination

Expert infectious disease specialist Dr. Mario Panaligan discusses evidence on the need for influenza vaccines, and the intricacies for making the best choice of vaccine.

Death, adverse health outcomes higher for COVID-19 than influenza after hospital admission

Certain lupus patients prone to flares after COVID-19 vaccination

Among Asian patients with systemic lupus erythematosus (SLE), those who are younger, male, from ethnic minority backgrounds, and have suboptimal disease control at time of vaccination are at increased risk of flares following mRNA COVID-19 vaccination.

Early oral antibiotic switch a good alternative to prolonged IV treatment in gram-negative bacteraemia

In the treatment of uncomplicated gram-negative bacteraemia, switching to oral antibiotics within 4 days appears to be effective, with the all-cause mortality risk comparable to that of continued intravenous (IV) antibiotic treatment, according to a study.

One-time ceftriaxone cuts ventilator-associated pneumonia risk

A single dose of ceftriaxone appears to reduce the risk of developing early ventilator-associated pneumonia (VAP) in patients with acute brain injury, according to the PROPHY-VAP study.